Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Rapid painful swelling, erythema with systemic illness, hypotension/confusion, new breathlessness/chest pain or acute unilateral swelling needs urgent assessment for cellulitis/sepsis, DVT or PE rather than routine lymphoedema treatment.
Synopsis
Diagnose chronic lymphatic swelling, exclude dangerous mimics and use decongestive therapy, skin care and cellulitis prevention safely.
Lymphoedema is protein-rich interstitial swelling from impaired lymph transport; it may be primary or secondary to cancer treatment, nodal disease, infection, obesity, trauma or chronic venous disease.
Early swelling may pit and improve overnight; later fibrosis, skin thickening and papillomatosis make it firm and non-pitting.
A positive Stemmer sign supports lymphoedema, but a negative sign does not exclude it.
Key red flags
Cellulitis
New warmth, tenderness, erythema/blotchy rash, rapid swelling, fever or flu-like symptoms; systemic toxicity requires emergency care.
Investigation priorities
01
Structured limb examination and volume/circumference measurementsFirst step
Confirm distribution, stage severity and provide a reproducible baseline.
Management branches
new swellingFirst assessment
Persistent limb or midline swelling suggestive of lymphatic failure.
First: establish onset, cancer/nodal treatment, infection, travel, drugs, venous history and cardiac/renal/liver symptoms; examine both limbs and nodes.
Next: urgently exclude DVT, cellulitis and malignant/central obstruction when clinical features suggest them.
maintenanceLong-term self-management
Volume reduced or stable chronic lymphoedema.
Key medicines
Flucloxacillin500 mg–1 g orally every 6 hours for 14 days for uncomplicated cellulitis in established lymphoedema.
Clarithromycin500 mg orally twice daily for 14 days.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.